Determinants of mortality and loss to follow-up among adults Enrolled in HIV care services in Rwanda

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Mugisha, Veronicah ^a,b   Teasdale, Chloe A ^a,b   Wang, Chunhui ^a,b   Lahuerta, Maria ^a,b   Nuwagaba Biribonwoha, Harriet ^a,b   Tayebwa, Edwin ^a   Ingabire, Eugenie ^a   Ingabire, Pacifique ^b   Sahabo, Ruben ^a   Twyman, Peter ^a,c,d   Abrams, Elaine J ^a,b  

^a Department of Medicine   (United States)

^b International Center for AIDS Care and Treatment Programs Columbia University ^*  (United States)

^c Ministry of Health of Rwanda   (Rwanda)

^d Keep A Child Alive Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORTALITY; PATIENT ATTITUDE; REFUSAL TO PARTICIPATE; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; RWANDA; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RWANDA; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84896277427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085774     Document Type: Article

References (36)

1. UNAIDS(2012) World AIDS Day Report Geneva, Switzerland: UNAIDS
2. Lowrance DW, Ndamage F, Kayirangwa E, Ndagije F, Lo W, et al.(2009) Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005. Journal of acquired immune deficiency syndromes 52: 49-55
3. Rwanda MoH(2011) Annual report July 2010 - June 2011. Kigali, Rwanda: Government of Rwanda
4. WHO(2011) Global HIV/AIDS Response: Epidemic update and health sector progress towards Universal Access. In: HIV/AIDS, editor editors. Geneva, Switzerland: World Health Organization
5. (2006) Human Resources for Health Strategic Plan 2006-2010. In: R. Ministry of Health, editor editors. Kigali, Rwanda: Government of Rwanda
6. Shumbusho F, van Griensven J, Lowrance D, Turate I, Weaver MA, et al.(2009) Task shifting for scale-up of HIV care: evaluation of nurse-centered antiretroviral treatment at rural health centers in Rwanda. PLoS medicine 6: e1000163
7. El-Sadr WM, Holmes CB, Mugyenyi P, Thirumurthy H, Ellerbrock T, et al.(2012) Scale-up of HIV treatment through PEPFAR: a historic public health achievement. Journal of acquired immune deficiency syndromes 60 Suppl 3: S96-104
8. Mugglin C, Estill J, Wandeler G, Bender N, Egger M, et al.(2012) Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-Analysis. Tropical medicine & international health: TM & IH
9. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, et al.(2009) Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC public health 9: 290
10. Lessells RJ, Mutevedzi PC, Cooke GS, Newell ML(2011) Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. Journal of acquired immune deficiency syndromes 56: e79-86
11. Hassan AS, Fielding KL, Thuo NM, Nabwera HM, Sanders EJ, et al.(2012) Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study. Tropical medicine & international health: TM & IH 17: 82-93
12. Ingle SM, May M, Uebel K, Timmerman V, Kotze E, et al.(2010) Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage study. Aids 24: 2717-2725
13. Mulissa Z, Jerene D, Lindtjorn B(2010) Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia. PloS one 5: e13268
14. Amuron B, Levin J, Birunghi J, Namara G, Coutinho A, et al.(2011) Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS research and therapy 8: 39
15. Wandeler G, Keiser O, Pfeiffer K, Pestilli S, Fritz C, et al.(2012) Outcomes of antiretroviral treatment programs in rural Southern Africa. Journal of acquired immune deficiency syndromes 59: e9-16
16. Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, et al.(2011) Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. Journal of acquired immune deficiency syndromes 58: e75-86
17. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, et al.(2009) Loss to care and death before antiretroviral therapy in Durban, South Africa. Journal of acquired immune deficiency syndromes 51: 135-139
18. Ford N, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, et al.(2010) Early initiation of antiretroviral therapy and associated reduction in mortality, morbidity and defaulting in a nurse-managed, community cohort in Lesotho. Aids 24: 2645-2650
19. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R(2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. Aids 22: 1897-1908
20. May M, Boulle A, Phiri S, Messou E, Myer L, et al.(2010) Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376: 449-457
21. Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, et al.(2012) Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study. PLoS medicine 9: e1001304
22. Druyts E, Dybul M, Kanters S, Nachega J, Birungi J, et al.(2012) Male gender and the risk of mortality among individuals enrolled in antiretroviral treatment programs in Africa: A systematic review and meta-Analysis. Aids
23. Boulle A, Van Cutsem G, Hilderbrand K, Cragg C, Abrahams M, et al.(2010) Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. Aids 24: 563-572
24. Rwanda Rd(2003) [French] Guide d'utilisation des medicaments antiretroviraux chez l'adulte et l'enfant. In: M. d. l. Sante, editor editors. Kigali, Rwanda: Government of Rwanda
25. Rwanda Ro(2009) Guidelines for the provision of comprehensive care to persons infected with HIV in Rwanda. In: M. o. Health, editor editors. Kigali, Rwanda: Government of Rwanda
26. Fine JP, Gray RJ(1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509
27. Rogers WH(1993) Regression standard errors in clustered samples. Stata Technical Bulletin Reprints 3 88-94
28. Williams RL(2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56: 645-646 (Pubitemid 30422662)
29. Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, et al.(2008) Overestimates of survival after HAART: implications for global scale-up efforts. PloS one 3: e1725
30. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, et al.(2008) Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. Journal of acquired immune deficiency syndromes 47: 101-107 (Pubitemid 351619376)
31. Weigel R, Hochgesang M, Brinkhof MW, Hosseinipour MC, Boxshall M, et al(2011) Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC infectious diseases 11: 31
32. Rich ML, Miller AC, Niyigena P, Franke MF, Niyonzima JB, et al.(2012) Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda. Journal of acquired immune deficiency syndromes 59: e35-42
33. Rosen S, Fox MP, Gill CJ(2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS medicine 4: e298
34. Mugglin C, Althoff K, Wools-Kaloustian K, Sterne J, Nash D, et al.(2012) Immunodeficiency at the start of ART: global view. Conference on Retrovirus and Opportunistic Infections. Seattle, Washington
35. Elul B, Basinga P, Nuwagaba-Biribonwoha H, Saito S, Horowitz D, et al.(2013) High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PloS one 8: e53586
36. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R(2009) The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical medicine & international health: TM & IH 14: 722-731.